Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Queen RX vs WeightCare

Queen RX
Graded #214

Higher grade

vs+7.399999999999999
WeightCare
Graded #368

Lower grade

The verdict

Queen RX takes it — 66/100 to 58.6/100.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +41
76
35
Dose & formulationWeightCare +5
57
62
Clinical oversightWeightCare +18
69
87
Labs & monitoringWeightCare +1
53
54
FulfillmentQueen RX +3
75
72
Contract termsQueen RX +20
61
41
Queen RX · left barWeightCare · right bar

The numbers

MetricQueen RXWeightCare
WeighScore66/10058.6/100
GradeCC
Scorecard rank#214#368
Semaglutide$100/mo (quarterly plan, compounded)$399/mo
TirzepatideNot disclosed$499/mo (15 mg dose, compounded)
Coverage45 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Queen RX

Graded #214 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV
WeightCare

Graded #368 · C

Strengths

  • PCAB-accredited pharmacy partners — strongest pharmacy quality signal
  • Quality testing: potency and sterility per USP 797 standards
  • 85,000+ members since 2022 — established patient base
  • Multiple program tiers for semaglutide
  • Health coaching, dietitians, fitness trainers included

Where it loses points

  • No LegitScript certification on the site itself
  • State availability not explicitly listed
  • Compounded only — no brand-name options
  • Semaglutide runs $215-$399/mo and tirzepatide $275-$499/mo depending on plan length and dose

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard